Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer – report on clinical outcome and dose to critical organs
- 30 April 2008
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 87 (1) , 24-28
- https://doi.org/10.1016/j.radonc.2008.02.015
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison in prognosis after VATS lobectomy and open lobectomy for stage I lung cancerSurgical Endoscopy, 2007
- Prospective study on stereotactic radiotherapy of limited-stage non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patientsLung Cancer, 2006
- Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomasCancer, 2002
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995